Rate of Sentinel Lymph Node Biopsy for T2 and T3 Cutaneous Melanoma at an Independent Academic Medical Center: Observations and Lessons Learned as Part of a Quality Improvement Project
Restricted accessBrief reportFirst published online December, 2015
Rate of Sentinel Lymph Node Biopsy for T2 and T3 Cutaneous Melanoma at an Independent Academic Medical Center: Observations and Lessons Learned as Part of a Quality Improvement Project
NCCN Clinical Practice Guidelines in Oncology. Melanoma Version 4.2014. Available at: http://nccn.org. Accessed July 28, 2014.
2.
MortonD.L., ThompsonJ.F., CochranA.J.Final trial report of sentinel-node biopsy versus nodal observation in melanoma.N Engl J Med2014; 370: 599–609.
3.
MortonD.L., ThompsonJ.F., CochranA.J.Sentinel-node biopsy or nodal observation in melanoma.N Engl J Med2006; 355: 1307–17.
4.
EricksonJ.L., VelascoJ.M., HiekenT.J.Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables.Ann Surg Oncol2008; 15: 1211–7.
